4/A

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: September 21, 2018
Period of Report: July 18, 2018
Accession Number: 0001177648-18-000034

View Document ↗ View on SEC.gov ↗